Spyre Therapeutics Inc. (SYRE) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Spyre Therapeutics Inc.

    NASDAQ: SYRE · Real-Time Price · USD
    15.89
    -0.09 (-0.56%)
    At close: Oct 03, 2025, 3:59 PM
    15.60
    -1.83%
    After-hours: Oct 03, 2025, 04:51 PM EDT

    Spyre Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -5.26 -0.44 -0.45 -4.75
    PEG Ratio
    		 0.05 -0.01 0.71 0.14
    PS Ratio
    		 n/a 167.52 16.28 16.67
    PB Ratio
    		 2.11 0.81 0.75 3.72
    P/FCF Ratio
    		 -6.96 -1.49 -0.47 -5.75
    P/OCF Ratio
    		 -6.96 -1.49 -0.47 -5.81
    OCF/S Ratio
    		 n/a -112.77 -34.41 -2.87
    Debt / Equity Ratio
    		 n/a 0.46 0.09 0.06
    Quick Ratio
    		 11.26 10.68 4.25 4.91
    Current Ratio
    		 11.26 10.68 4.25 4.91
    Asset Turnover
    		 n/a 0.00 0.03 0.17
    Interest Coverage
    		 n/a n/a n/a n/a
    Return on Equity
    		 -0.4 -1.84 -1.67 -0.78
    Return on Assets
    		 -0.34 -0.99 -1.18 -0.6
    Return on Invested Capital
    		 -0.38 -0.78 -1.48 -0.73
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a 1.00 1.00 1.00
    Net Profit Margin
    		 n/a -382.38 -35.99 -3.51
    Pretax Profit Margin
    		 n/a -382.41 -36.05 -3.5
    Operating Profit Margin
    		 n/a -273.48 -36.4 -3.5
    FCF Margin
    		 n/a -112.77 -34.43 -2.9
    EBITDA Margin
    		 n/a -144.02 -35.56 -3.42

    Add to Watchlist